Reproducible Quantification of Regional Sympathetic Denervation with [


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
12 2021
Historique:
received: 12 12 2019
accepted: 13 03 2020
pubmed: 30 4 2020
medline: 25 3 2022
entrez: 30 4 2020
Statut: ppublish

Résumé

Regional cardiac sympathetic denervation is predictive of sudden cardiac arrest in patients with ischemic cardiomyopathy. The reproducibility of denervation scores between automated software programs has not been evaluated. This study seeks to (1) compare the inter-rater reliability of regional denervation measurements using two analysis programs: FlowQuant N = 190 dynamic [ Inter-observer, inter-software, and test-retest ICC values were excellent (ICC = 94% to 99%) and measurement variability was small (RPC < 11%). Mean differences between observers ranged .2% to 1.1% for Corridor4DM (P = .28), FlowQuant (P < .001), and between software programs (P < .001). Kaplan-Meier analysis demonstrated HED scores from both programs were predictive of SCA. Inter-rater reliability for both analysis programs was excellent and test-retest repeatability was consistent. The minimal difference in scores between FlowQuant and Corridor4DM supports their use in future trials.

Sections du résumé

BACKGROUND
Regional cardiac sympathetic denervation is predictive of sudden cardiac arrest in patients with ischemic cardiomyopathy. The reproducibility of denervation scores between automated software programs has not been evaluated. This study seeks to (1) compare the inter-rater reliability of regional denervation measurements using two analysis programs: FlowQuant
METHODS
N = 190 dynamic [
RESULTS
Inter-observer, inter-software, and test-retest ICC values were excellent (ICC = 94% to 99%) and measurement variability was small (RPC < 11%). Mean differences between observers ranged .2% to 1.1% for Corridor4DM (P = .28), FlowQuant (P < .001), and between software programs (P < .001). Kaplan-Meier analysis demonstrated HED scores from both programs were predictive of SCA.
CONCLUSION
Inter-rater reliability for both analysis programs was excellent and test-retest repeatability was consistent. The minimal difference in scores between FlowQuant and Corridor4DM supports their use in future trials.

Identifiants

pubmed: 32347526
doi: 10.1007/s12350-020-02114-3
pii: 10.1007/s12350-020-02114-3
pmc: PMC7673573
mid: NIHMS1631611
doi:

Substances chimiques

Contrast Media 0
3-hydroxyephedrine 3002-40-2
Ephedrine GN83C131XS

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2745-2757

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL130266
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001412
Pays : United States
Organisme : CIHR
Pays : Canada

Informations de copyright

© 2020. American Society of Nuclear Cardiology.

Références

Zelt JGE, DeKemp RA, Rotstein BH, Nair GM, Narula J, Ahmadi A, et al. Nuclear imaging of the cardiac sympathetic nervous system: A disease-specific interpretation in heart failure. JACC Cardiovasc Imaging 2019. https://doi.org/10.1016/j.jcmg.2019.01.042 .
doi: 10.1016/j.jcmg.2019.01.042 pubmed: 31326479
Boutagy NE, Sinusas AJ. Recent advances and clinical applications of PET cardiac autonomic nervous system imaging. Curr Cardiol Rep 2017;19:33.
doi: 10.1007/s11886-017-0843-0
Boschi S, Lodi F, Boschi L, Nanni C, Chondrogiannis S, Colletti PM, et al. 11C-meta-hydroxyephedrine: A promising PET radiopharmaceutical for imaging the sympathetic nervous system. Clin Nucl Med 2015;40:e96-e103.
doi: 10.1097/RLU.0000000000000512
Bengel FM. Imaging targets of the sympathetic nervous system of the heart: Translational considerations. J Nucl Med 2011;52:1167-70.
doi: 10.2967/jnumed.110.084228
Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM Jr. Denervated myocardium is preferentially associated with sudden cardiac arrest in ischemic cardiomyopathy: A pilot competing risks analysis of cause-specific mortality. Circ Cardiovasc Imaging 2017. https://doi.org/10.1161/CIRCIMAGING.117.006446 .
doi: 10.1161/CIRCIMAGING.117.006446 pubmed: 28794139 pmcid: 5555076
Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141-9.
doi: 10.1016/j.jacc.2013.07.096
Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993;22:368-75.
doi: 10.1016/0735-1097(93)90039-4
Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983;67:787-96.
doi: 10.1161/01.CIR.67.4.787
Simoes M, Barthel P, Matsunari I, Nekolla SG, Schömig A, Schwaiger M, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J 2004;25:551-7.
doi: 10.1016/j.ehj.2004.02.016
Lautamaki R, Sasano T, Higuchi T, Nekolla SG, Lardo AC, Holt DP, et al. Multiparametric molecular imaging provides mechanistic insights into sympathetic innervation impairment in the viable infarct border zone. J Nucl Med 2015;56:457-63.
doi: 10.2967/jnumed.114.149971
Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2008;51:2266-75.
doi: 10.1016/j.jacc.2008.02.062
Thackeray JT, Renaud JM, Kordos M, Klein R, Dekemp RA, Beanlands RS, et al. Test–retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography. Nuc Med Bio 2013;40:676-81.
doi: 10.1016/j.nucmedbio.2013.03.007
Wang T, Wu KY, Miner RC, Renaud JM, Beanlands RSB, deKemp RA. Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging. EJNMMI Res 2018;8:63.
doi: 10.1186/s13550-018-0421-5
Harms HJ, de Haan S, Knaapen P, Allaart CP, Rijnierse MT, Schuit RC, et al. Quantification of [11 C]-meta-hydroxyephedrine uptake in human myocardium. EJNMMI Res 2014;4:52.
doi: 10.1186/s13550-014-0052-4
Wu KY, Zelt JGE, Wang T, Dinculescu V, Miner R, Lapierre C, et al. Reliable quantification of myocardial sympathetic innervation and regional sympathetic denervation using [
doi: 10.1007/s00259-019-04629-5
Ather S, Iqbal F, Gulotta J, Aljaroudi W, Heo J, Iskandrian AE, et al. Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2014;21:673-81.
doi: 10.1007/s12350-014-9885-5
Fallavollita JA, Luisi AJ Jr, Michalek SM, Valverde AM, deKemp RA, Haka MS, et al. Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods. Contemp Clin Trials 2006;27:374-88.
doi: 10.1016/j.cct.2006.03.005
Hall AB, Ziadi MC, Leech JA, Chen SY, Burwash IG, Renaud J, et al. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: A randomized study. Circulation 2014;130:892-901.
doi: 10.1161/CIRCULATIONAHA.113.005893
Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: A false transmitter agent for heart neuronal imaging. J Nucl Med 1990;31:1328-34.
pubmed: 2384800
Garcia EV, Slomka P, Moody JB, Germano G, Ficaro EP. Quantitative clinical nuclear cardiology. Part 1: Established applications. J Nucl Cardiol 2019;60:1507-16.
Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, et al. Clinical interpretation standards and quality assurance for the multicenter PET/CT trial Rubidium-ARMI. J Nucl Med 2014;55:58-64.
doi: 10.2967/jnumed.112.117515
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155-63.
doi: 10.1016/j.jcm.2016.02.012
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010;47:931-6.
doi: 10.1016/j.ijnurstu.2009.10.001
Morgan WA. A test for the significance of the difference between the two variances in a sample from a normal bivariate population. Biometrika 1939;31:13-9.
Harms HJ, Huisman MC, Rijnierse MT, Greuter H, Hsieh YL, de Haan S, et al. Noninvasive quantification of myocardial 11C-meta-hydroxyephedrine kinetics. J Nucl Med 2016;57:1376-81.
doi: 10.2967/jnumed.115.167437
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol 2010;55:2212-21.
doi: 10.1016/j.jacc.2010.01.014
Narula J, Gerson M, Thomas GS, Cerqueira MD, Jacobson AF.
doi: 10.2967/jnumed.115.156406
Bateman TM, Ananthasubramaniam K, Berman DS, Gerson M, Gropler R, Henzlova M, et al. Reliability of the
doi: 10.1007/s12350-017-1183-6
Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac iodine-123 MIBG imaging. J Nucl Cardiol 2011;18:82-9.
doi: 10.1007/s12350-010-9313-4

Auteurs

Jean Z Wang (JZ)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Jonathan B Moody (JB)

INVIA Medical Imaging Solutions, Ann Arbor, Michigan, USA.

Nicole Kaps (N)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.

Deron Britt (D)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Aaryn Lavallee (A)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.

Jennifer M Renaud (JM)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
INVIA Medical Imaging Solutions, Ann Arbor, Michigan, USA.

Jason G E Zelt (JGE)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Kai Yi Wu (KY)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Rob S Beanlands (RS)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

James A Fallavollita (JA)

Division of Cardiovascular Medicine, University at Buffalo, Buffalo, NY, USA.
VA Western New York Healthcare System, Buffalo, NY, USA.

John M Canty (JM)

Division of Cardiovascular Medicine, University at Buffalo, Buffalo, NY, USA.
VA Western New York Healthcare System, Buffalo, NY, USA.

Robert A deKemp (RA)

Department of Medicine (Cardiology), University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, ON, K1Y 4W7, Canada. RAdeKemp@ottawaheart.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH